Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01365884 · ClinicalTrials.gov registry record
First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01365884: Clinical Trial study, sponsored by University of Nebraska.
NCT01365884 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01365884 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Proof of concept study to compare the best corrected visual acuity obtained via First-Sight lenses with the autorefraction in children.
Primary Outcome
Will measure children's vision with First-Sight refracting kit and compare it to the two standard methods used in clinics.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-08-05 |
| Est. Completion | 2014-02-12 |
Why NCT01365884 stopped before completion
NCT01365884 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01365884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01365884 about?
NCT01365884 is a clinical study titled "First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age". Proof of concept study to compare the best corrected visual acuity obtained via First-Sight lenses with the autorefraction in children.
What is the current status of trial NCT01365884?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2011-08-05. Estimated completion is 2014-02-12.
Who is sponsoring clinical trial NCT01365884?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI